Literature DB >> 7580774

Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease.

G P Krestin1, G Kacl, M Hauser, G Keusch, H R Burger, R Hoffmann.   

Abstract

BACKGROUND: Sclerosing peritonitis (SP) is a serious complication of chronic ambulatory peritoneal dialysis (CAPD) that is characterized by thickened peritoneal membranes, leading to impaired ultrafiltration and intestinal obstruction. The aim of this study was to analyze the radiographic signs of SP in symptomatic patients and to compare them with the histological severity of the disease.
METHODS: In 14 patients with symptoms of intestinal obstruction related to SP, plain films of the abdomen, upper GI follow-through examinations, ultrasonography, and computed tomography were evaluated retrospectively. Imaging findings such as bowel motility, bowel wall and peritoneal thickness, and the presence of intraperitoneal fluid collections were correlated to the histological degree of the fibrosis.
RESULTS: Signs of intestinal obstruction and disturbed motility were present in all cases. In addition, patients with histologically severe SP had loculated fluid collections, thickening of the bowel wall and/or peritoneum, peritoneal calcifications, and thickened peritoneal membranes, and suffered more often from postoperative complications.
CONCLUSION: The detection of characteristic radiographic signs in CAPD patients presenting with symptoms of intestinal obstruction may suggest the presence of severe SP and should lead to cautious surgical interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7580774     DOI: 10.1007/BF01213261

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  13 in total

Review 1.  Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.

Authors:  J W Dobbie
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

2.  Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis.

Authors:  A S Hollman; M A McMillan; J D Briggs; B J Junor; P Morley
Journal:  Clin Radiol       Date:  1991-03       Impact factor: 2.350

3.  Sclerosing peritonitis after CAPD.

Authors:  J A Bradley; D N Hamilton; D L McWhinnie; J D Briggs; B J Junor
Journal:  Lancet       Date:  1983-09-03       Impact factor: 79.321

4.  Peritoneal permeability and encapsulating peritonitis.

Authors:  C Verger; B Celicout
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

5.  Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management.

Authors:  W K Eltringham; H J Espiner; C W Windsor; D A Griffiths; J D Davies; H Baddeley; A E Read; R J Blunt
Journal:  Br J Surg       Date:  1977-04       Impact factor: 6.939

6.  Sclerosing peritonitis and propranolol.

Authors:  S Ahmad
Journal:  Chest       Date:  1981-03       Impact factor: 9.410

7.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

Authors:  V C Gandhi; H M Humayun; T S Ing; J T Daugirdas; V R Jablokow; S Iwatsuki; W P Geis; J E Hano
Journal:  Arch Intern Med       Date:  1980-09

8.  Peritoneal encapsulation and abdominal cocoon. Case reports and a review of the literature.

Authors:  J O Sieck; R Cowgill; W Larkworthy
Journal:  Gastroenterology       Date:  1983-06       Impact factor: 22.682

9.  Sclerosing peritonitis with gross peritoneal calcification: a case report.

Authors:  S V Cox; J Lai; M Suranyi; N Walker
Journal:  Am J Kidney Dis       Date:  1992-12       Impact factor: 8.860

10.  Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen.

Authors:  A Korzets; Z Korzets; G Peer; J Papo; D Stern; J Bernheim; M Blum
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

View more
  12 in total

Review 1.  Encapsulating peritonitis and familial Mediterranean fever.

Authors:  Resat Dabak; Oya Uygur-Bayramiçli; Didem-Kiliç Aydin; Can Dolapçioglu; Cengiz Gemici; Turgay Erginel; Cem Turan; Nimet Karadayi
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

2.  Abdominal cocoon syndrome: an obstructive adhesiolytic metamorphosis.

Authors:  Abagayle E Renko; Samantha R Witte; Amanda B Cooper
Journal:  BMJ Case Rep       Date:  2019-04-11

3.  American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy.

Authors:  Rajnish Mehrotra; Richard J Glassock; Anthony J Bleyer
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

Review 4.  Abdominal cocoon: report of a case.

Authors:  M Kumar; M Deb; R Parshad
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Abdominal cocoon secondary to disseminated tuberculosis.

Authors:  Radha Puppala; Smiti Sripathi; Rajagopal Kadavigere; Prakashini Koteshwar; Jyoti Singh
Journal:  BMJ Case Rep       Date:  2014-09-19

6.  Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis.

Authors:  Ruth M Tarzi; Adrian Lim; Steven Moser; Sohail Ahmad; Abraham George; Gowrie Balasubramaniam; Elaine J Clutterbuck; Wladyslaw Gedroyc; Edwina A Brown
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

7.  Abdominal cocoon secondary to tuberculosis.

Authors:  Rajul Rastogi
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

Review 8.  [Diseases of the peritoneum and mesenterium].

Authors:  A Ba-Ssalamah; M Uffmann; N Bastati; W Schima
Journal:  Radiologe       Date:  2009-07       Impact factor: 0.635

9.  Imaging in encapsulating peritoneal sclerosis.

Authors:  Anniek Vlijm; Joost van Schuppen; Armand B G N Lamers; Dirk G Struijk; Raymond T Krediet
Journal:  NDT Plus       Date:  2011-06-17

10.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.